Q4 results: revenue growth from dealer inventory normalization and share gains; 2026 demand subdued but rebound could lift stock 37%.
The European cannabis wholesale business was weak in Q4 due to transitory disruption in Portugal. Remexian's performance should recover. The ecommerce segment has continued to weaken High Tide's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results